Back
Weyco Group 10K Form
Buy
62
WEYS
Weyco Group
Last Price:
36.84
Seasonality Move:
3.71%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | WEYS/Weyco Group Quarterly |
| 2023-11-09 | 10Q | WEYS/Weyco Group Quarterly |
| 2023-08-09 | 10Q | WEYS/Weyco Group Quarterly |
| 2023-05-10 | 10Q | WEYS/Weyco Group Quarterly |
| 2022-11-07 | 10Q | WEYS/Weyco Group Quarterly |
| 2022-08-08 | 10Q | WEYS/Weyco Group Quarterly |
Receive WEYS News And Ratings
See the #1 stock for the next 7 days that we like better than WEYS
WEYS Financial Statistics
Sales & Book Value
| Annual Sales: | $318.05M |
|---|---|
| Cash Flow: | $-930K |
| Price / Cash Flow: | 6.79 |
| Annual Sales: | $27.20 |
| Price / Book: | 1.35 |
Profitability
| EPS (TTM): | 3.02000 |
|---|---|
| Net Income (TTM): | $28.86M |
| Gross Margin: | $142.88M |
| Return on Equity: | 11.66% |
| Return on Assets: | 9.49% |
Weyco Group Earnings Forecast
Key Weyco Group Financial Ratios
- The Gross Profit Margin over the past 40 years for WEYS is 44.92%.
- The Selling, General & Administrative Expenses for WEYS have been equal to 32.03% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 1.75% of Operating Income.
- The Net Earning history of WEYS is 9.49% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 28 years.
Weyco Group Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Distributors |
| Sector: | Consumer Discretionary |
| Current Symbol: | WEYS |
| CUSIP: | 962149 |
| Website: | weycogroup.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 8.62 |
| Quick Ratio: | 5.34 |
Price-to-Earnings
| Trailing P/E Ratio: | 11.5 |
|---|---|
| Forward P/E Ratio: | 0 |
WEYS Technical Analysis vs Fundamental Analysis
Buy
62
Weyco Group (WEYS)
is a Buy
Is Weyco Group a Buy or a Sell?
-
Weyco Group stock is rated a Buy
The current Weyco Group [WEYS] share price is $36.45. The Score for WEYS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.